ADDITIONAL INFORMATION CONTINUED REMUNERATION OF DIRECTORS 2024 Salary/fees $ Bonus $ Super– annuation $ Share based payments $ Total $ Non–Executive Directors Patrick Davies 157,500 – – – 157,500 Dr Trevor Scott (retired 30 June 2024) 37,500 – – – 37,500 Dianne Angus 78,627 – 8,873 – 87,500 Dr Jenny Harry 80,869 – 9,131 – 90,000 Joe Basile 90,000 – – – 90,000 444,496 – 18,004 – 462,500 Executive Directors Jon Pilcher 621,334 - 28,665 18,402 668,402 Total 1,065,830 - 46,670 18,402 1,130,902 2023 Salary/fees $ Bonus $ Super– annuation $ Share based payments $ Total $ Non–Executive Directors Patrick Davies 125,000 – – – 125,000 Dr Trevor Scott 75,000 – – – 75,000 Dianne Angus 67,720 – 7,280 – 75,000 Dr Jenny Harry 67,720 – 7,280 – 75,000 Joe Basile 60,124 – 2,376 – 62,500 395,564 – 16,935 – 412,499 Executive Directors Jon Pilcher 548,654 500,000 26,346 289,404 1,364,404 Total 944,219 500,000 43,280 289,404 1,776,903 Loan Funded Shares Jon Pilcher has an interest in 1,500,000 Loan Funded Shares held by Neuren Trustee Limited. As detailed in Note 16 to the Financial Statements, the Loan Funded Shares are subject to repayment of a loan amounting to $1.84 per share ($2,760,000) before they can be transferred to Jon. Neuren Pharmaceuticals Limited Annual Report 2024 52
RkJQdWJsaXNoZXIy MjE2NDg3